{"entity":{"type":"insider","cik":"0001975022","url":"/insider/0001975022","json_url":"/insider/0001975022.json","name":"Rozek Elizabeth","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2024-07-23","last":"2026-07-22","span_basis":"filed_date"},"name_variants":[{"name":"Rozek Elizabeth","source":"filing","n_filings":4,"first_seen":"2024-07-23","last_seen":"2026-07-22"}],"transactions":[{"id":5963999,"accession":"0001193125-26-312394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-312394","line_url":"/filing/0001193125-26-312394#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001975022","owner_name":"Rozek Elizabeth","owner_url":"/insider/0001975022","role":"Officer (Chief Legal & Admin. Officer)","officer_title":"Chief Legal & Admin. Officer","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10545.0,"shares_display":"10,545","price_per_share":7.7603,"price_display":"7.76","price_state":"stated","total_value":81832.3635,"total_display":"81,832.36","shares_owned_after":224414.0,"shares_owned_after_display":"224,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-20","filed_date":"2026-07-22","scope":"insider"},{"id":6071036,"accession":"0001104659-26-014266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-014266","line_url":"/filing/0001104659-26-014266#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001975022","owner_name":"Rozek Elizabeth","owner_url":"/insider/0001975022","role":"Officer (Chief Legal & Admin. Officer)","officer_title":"Chief Legal & Admin. Officer","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2622.0,"shares_display":"2,622","price_per_share":5.3602,"price_display":"5.36","price_state":"stated","total_value":14054.4444,"total_display":"14,054.44","shares_owned_after":190959.0,"shares_owned_after_display":"190,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-12","scope":"insider"},{"id":4955851,"accession":"0001104659-25-070013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-070013","line_url":"/filing/0001104659-25-070013#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001975022","owner_name":"Rozek Elizabeth","owner_url":"/insider/0001975022","role":"Officer (General Counsel and CCO)","officer_title":"General Counsel and CCO","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10780.0,"shares_display":"10,780","price_per_share":9.1346,"price_display":"9.13","price_state":"stated","total_value":98470.988,"total_display":"98,470.99","shares_owned_after":183726.0,"shares_owned_after_display":"183,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-21","filed_date":"2025-07-23","scope":"insider"},{"id":2538066,"accession":"0001104659-24-081891","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-081891","line_url":"/filing/0001104659-24-081891#line-1","is_derivative":false,"issuer_cik":"0001400118","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001400118","owner_cik":"0001975022","owner_name":"Rozek Elizabeth","owner_url":"/insider/0001975022","role":"Officer (General Counsel and CCO)","officer_title":"General Counsel and CCO","security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10914.0,"shares_display":"10,914","price_per_share":3.0997,"price_display":"3.10","price_state":"stated","total_value":33830.1258,"total_display":"33,830.13","shares_owned_after":160506.0,"shares_owned_after_display":"160,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-19","filed_date":"2024-07-23","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001400118","name":"Sagimet Biosciences Inc.","url":"/issuer/0001400118","role":"Officer (Chief Legal & Admin. Officer)","n_filings":4,"first_seen":"2024-07-23","last_seen":"2026-07-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001975022","retrieved_at":"2026-08-21T21:06:54+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}